Author:
Yamamoto Katsuya,Kawamoto Shinichiro,Kitao Akihito,Mizutani Yu,Inui Yumiko,Yakushijin Kimikazu,Kajimoto Kazuyoshi,Hayashi Yoshitake,Matsuoka Hiroshi,Minami Hironobu
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Merron B, Davies A. Double hit lymphoma: how do we define it and how do we treat it? Best Pract Res Clin Haematol. 2018;31:233–40.
2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.
3. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273–9.
4. McPhail ED, Maurer MJ, Macon WR, Feldman AL, Kurtin PJ, Ketterling RP, et al. Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements. Haematologica. 2018;103:1899–907.
5. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations and gene fusions in cancer. (2019).
https://cgap.nci.nih.gov/Chromosomes/Metelman
. Accessed 20 Jan 2019.